COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma

NCT00081627 Phase 2 COMPLETED

The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.

Details

Lead sponsor	Mast Therapeutics, Inc.
Phase	Phase 2
Status	COMPLETED
Enrolment	48
Start date	2004-04
Completion	2007-01

Conditions

• Colon Cancer
• Rectal Cancer

Interventions

• CoFactor and 5FU

Countries

United States, Serbia and Montenegro